Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01842958
Other study ID # CR 10/09
Secondary ID
Status Completed
Phase N/A
First received April 23, 2013
Last updated January 18, 2018
Start date March 2013
Est. completion date March 2016

Study information

Verified date January 2018
Source Institut Straumann AG
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary objective of this study is to demonstrate non-inferiority of the Straumann Bone Level Ø 3.3 mm NC SLActive Roxolid Implants compared to Straumann Bone Level Ø 4.1 mm RC SLActive Roxolid Implants based on mean crestal bone level changes measured between surgery and 12 months post-implant placement. The secondary objectives will assess differences in clinical outcomes between the test and control implants, including implant success and survival, gingival recession, subject satisfaction and additional early bone level measurements.


Description:

This is a randomized, controlled, multi-center clinical study. The total study duration for each patient should be 12 ± 1 months.

Straumann Bone Level implants will be placed in the pre-molar or anterior region of the mandible or maxilla for single tooth replacement, followed by provisional prosthetic loading after 25 ± 4 days and by final prosthetic loading 6 ± 1 months after implant loading.

In total 6 visits per patient are scheduled in this study. Bone level changes, implant success and survival, gingival recession, subject satisfaction and adverse events (AEs) will be assessed.

The study devices are CE-(Conformité Européenne, meaning European Conformity) marked products. Straumann Bone Level implants Ø 3.3 mm NC SLActive Roxolid and Straumann Bone Level Ø 4.1 mm RC SLActive implants.

Five centers in USA will participate.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date March 2016
Est. primary completion date January 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years and older
Eligibility Inclusion Criteria:

- Subjects must have voluntarily signed the informed consent form

- Subjects must be males or females who are a minimum of 20 years of age

- Subjects must have a single tooth gap in the pre-molar or anterior region of the mandible or maxilla (ADA tooth positions 4-13 and 20-29; FDI tooth positions 11-15, 21-25, 31-35, and 41-45)

- Subjects must have opposing dentition (natural teeth, fixed or removable restorations)

- Subjects must have a full mouth plaque score = 25%, according to O'Leary, at the time of screening

- Subjects must have adequate bone to encapsulate the implant and allow placement of an Ø 4.1 mm Bone Level Implant.

- Adequate bone height of at least 1 mm longer than the length of the study implant

- Subjects must have substantially healed (at least 16 weeks after tooth extraction) extraction sockets

- Subjects must be committed to the study and the required follow-up visits

- Subjects must be in good general health as assessed by the Investigator

Exclusion Criteria:

- Subjects with a systemic disease that would preclude dental implant surgery (e.g. serious internal medical problems, disorders of bone metabolism, uncontrolled bleeding disorders, weakened immune system, illness requiring periodic use of steroids, uncontrollable endocrine disorders, uncontrolled diabetes)

- Subjects with any contraindications for oral surgical procedures (e.g. inadequate wound healing capacity, poor oral hygiene, maxillary and mandibular growth not completed, xerostomia)

- Subjects with mucosal diseases (e.g., erosive lichen planus) in the localized area around the study implant site

- Subjects with a history of local irradiation therapy in the head/neck area

- Subjects with any untreated endodontic lesions or untreated periodontal disease adjacent to the implant site

- Subjects receiving, or having a history of receiving, intravenous or subcutaneous antiresorptive agents, such as bisphosphonates

- Subjects with severe bruxing, parafunctional habits, or temporomandibular joint dysfunction

- Subjects with existing implants in the adjacent positions to the planned implant site

- Subjects requiring bone augmentation or socket grafting within 6 months prior to surgery

- Subjects requiring more than minimal simultaneous augmentation for minimal buccal dehiscence defects (defect cannot be greater than 3mm in height)

- Subjects with inadequate oral hygiene or who are unmotivated for adequate home care

- Subjects who have physical or mental handicaps that would interfere with the ability to perform adequate oral hygiene

- Subjects who are pregnant or intending to become pregnant during the duration of the study

- Subjects who are heavy smokers (defined as >10 cigarettes per day or >1 cigar per day) or chew tobacco

- Subjects who abuse alcohol or drugs

- Subjects who have undergone administration of any investigational device within 30 days of enrollment in the study

- Subjects with conditions or circumstances, in the opinion of the Investigator, which would prevent completion of study participation or interfere with analysis of study results, such as history of non-compliance or unreliability

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Straumann Bone Level Implants, 4.1 mm implant diameter
Straumann Bone Level Implants, 4.1 mm implant diameter
Straumann Bone Level Implants, 3.3 mm implant diameter
Straumann Bone Level Implants, 3.3 mm implant diameter

Locations

Country Name City State
United States Boston University, School of Dental Medicine Boston Massachusetts
United States UCLA School of Dentistry Los Angeles California
United States New York University College of Dentistry New York New York
United States Univeristy of Texas Health Science Center San Antonio San Antonio Texas
United States University of Washington Seattle Washington

Sponsors (1)

Lead Sponsor Collaborator
Institut Straumann AG

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mean Crestal Bone Level Change Mean crestal bone level change between implant placement and 12 months post loading as determined by radiographic measurement of mesial and distal bone levels following placement of a Straumann Bone Level implant with 3.3 mm diameter versus a Straumann Bone Level implant with 4.1 mm diameter in the anterior or pre-molar region of the mandible or maxilla. Baseline (implant placement) and 12 months post loading
Secondary Additional Mean Crestal Bone Level Changes Additional radiographic evaluation of mesial and distal crestal bone level changes between implant placement and at 25 days post post implant placement, 6 months post loading, and 12 months post loading Baseline (implant placement), 25 days post implant placement, 6 months post loading, and 12 months post loading
Secondary Implant Success Rate Percentage of participants with successful and non-successful implant (definition of implant success according to Buser et al. 1991: Absence of persistent subjective complaints, such as pain, foreign body sensation and/ or dysesthesia; Absence of a recurrent peri-implant infection with suppuration; Absence of mobility; Absence of a continuous radiolucency around the implant) 25 days, 6 months post loading, and 12 months post loading
Secondary Implant Survival Rate Percentage of participants with surviving implant (a surviving implant is one that is in place at the time of follow-up) 7 days, 25 days, 6 months post loading, and 12 months post loading
Secondary Gingival Recession Soft tissue measurements include:
CLI = length of the implant crown from highest point of the soft tissue margin to the incisal edge IPm = distance from the top of the papilla to the incisal edge mesial of the implant crown IPd = distance from the top of the papilla to the incisal edge distal of the implant crown CLTm = length of the crown from highest point of soft tissue margin to the incisal edge of the adjacent mesial tooth CLTd = length of the crown from highest point of soft tissue margin to the incisal edge of the adjacent distal tooth
Reporting change in soft tissue measurements from 6 months post-loading (final restoration) to 12 months post-loading in millimeters.
6 months to 12 months post loading
Secondary Number of Participants With Adverse Events and Adverse Device Effects Adverse events were checked at each study visit at the following time points: Surgical visit, 7 days (post-op), 25 days (implant loading), 6 months post-loading and 12 months post-loading. The incidence of adverse events during the period of the study is reported here, along with the number of adverse events related to device and procedure (includes "possibly related", "probably related" and "related"). Duration of the study from surgical visit to the 12 months post-loading visit
Secondary Subject Satisfaction Subject satisfaction will be assessed utilizing Visual Analogs Scales (VAS) for general satisfaction and pain.
General satisfaction: ranged from 0 (not satisfied) to 100 (highly satisfied) Pain: ranged from 0 (no pain) to 100 (pain)
12 months post loading
See also
  Status Clinical Trial Phase
Recruiting NCT02880891 - Effects of Splinted or Non-splinted Single-unit Crowns on Marginal Bone-level Alterations Around Implants N/A
Completed NCT00748241 - Study to Evaluate Implant Survival Rate of Astra Tech Fixture ST in the Posterior Maxilla With One-stage Surgery and Early Loading N/A
Active, not recruiting NCT04066309 - Implant Retained Rehabilitation With Surgical and Prosthetic Digital Workflow N/A
Active, not recruiting NCT04545840 - Prospective Neodent® Zirconia System Study
Active, not recruiting NCT06034067 - Osseodensification Versus Conventional Drilling for Implant Site Preparation N/A
Active, not recruiting NCT04546269 - Fully Guided Versus Conventionally Guided Implant Placement by Dental Students N/A
Recruiting NCT02662361 - Evaluation of the Prevalence and Risk Factors for Patients With Peri-implant Disease:a Retrospective Study N/A
Recruiting NCT02676661 - Evaluation of the Prevalence and Risk Factors for Patients With Peri-implant Disease N/A
Completed NCT01030523 - Short Implants - An Alternative to Bone Grafting? N/A
Completed NCT00906425 - Clinical Study Comparing Submerged Versus Trans-mucosal Healing of P.004 Implants in the Anterior Mandible and Maxilla N/A
Completed NCT03252106 - Long-term Effectiveness of Contour Augmentation in Sites With Early Implant Placement N/A
Completed NCT02975674 - Evaluation of MT-12 Implant Survival and Marginal Bone Loss N/A
Completed NCT01822223 - A Study to Evaluate the Effectiveness of Laser-Ablated Implant-Abutments to Promote Tissue Healing N/A
Completed NCT00545818 - Study Comparing OsseoSpeed™ Implants of Two Different Lengths in the Upper and Lower Posterior Jaw N/A
Completed NCT00900822 - Straumann Bone Ceramic Versus BioOss in Sinus Elevation N/A
Completed NCT04017026 - Survival and Success Rates of 6mm Implants With a Micro-rough Surface After 4.5 - 18.2 Years in Function
Active, not recruiting NCT05315414 - Multicenter Study to Evaluate the Clinical Outcome of PrimeTaper EV Implant in Single Tooth Restorations N/A
Recruiting NCT02814149 - Esthetic, Clinical and Radiographic Outcomes of Immediate and Delayed Implant Placement N/A
Active, not recruiting NCT03319758 - Esthetic and Radiographic Outcomes Following Immediate Implant Placement With Thin or Dehiscence Buccal Bone Wall N/A
Completed NCT01807416 - Bone Dimensional Changes at Different Implant-to-abutment Connections: a 1-year Clinical and Radiological Study Phase 4